Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Fibrinogen inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H18N4O |
InChIKeyWNIBVFHPUQWWDO-UHFFFAOYSA-N |
CAS Registry956128-08-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | 09 Feb 2018 |